» Articles » PMID: 30449495

Dynamic Prediction of Overall Survival for Patients with High-grade Extremity Soft Tissue Sarcoma

Overview
Journal Surg Oncol
Date 2018 Nov 20
PMID 30449495
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: There is increasing interest in personalized prediction of disease progression for soft tissue sarcoma patients. Currently, available prediction models are limited to predictions from time of surgery or diagnosis. This study updates predictions of overall survival at different times during follow-up by using the concept of dynamic prediction.

Patients And Methods: Information from 2232 patients with high-grade extremity soft tissue sarcoma, who underwent surgery at 14 specialized sarcoma centers, was used to develop a dynamic prediction model. The model provides updated 5-year survival probabilities from different prediction time points during follow-up. Baseline covariates as well as time-dependent covariates, such as status of local recurrence and distant metastases, were included in the model. In addition, the effect of covariates over time was investigated and modelled accordingly in the prediction model.

Results: Surgical margin and tumor histology show a significant time-varying effect on overall survival. The effect of margin is strongest shortly after surgery and diminishes slightly over time. Development of local recurrence and distant metastases during follow-up have a strong effect on overall survival and updated predictions must account for their occurrence.

Conclusion: The presence of time-varying effects, as well as the effect of local recurrence and distant metastases on survival, suggest the importance of updating predictions during follow-up. This newly developed dynamic prediction model which updates survival probabilities over time can be used to make better individualized treatment decisions based on a dynamic assessment of a patient's prognosis.

Citing Articles

The reporting quality and methodological quality of dynamic prediction models for cancer prognosis.

Yan P, Xu Z, Hui X, Chu X, Chen Y, Yang C BMC Med Res Methodol. 2025; 25(1):58.

PMID: 40025462 PMC: 11872325. DOI: 10.1186/s12874-025-02516-2.


Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians.

Kruiswijk A, Vlug L, Acem I, Engelhardt E, Gronchi A, Callegaro D Ann Surg Oncol. 2025; 32(4):2958-2970.

PMID: 39893340 PMC: 11882627. DOI: 10.1245/s10434-024-16849-7.


The Importance of Patient Systemic Health Status in High-Grade Chondrosarcoma Prognosis: A National Multicenter Study.

van Praag V, Molenaar D, Tendijck G, Schaap G, Jutte P, van der Geest I Cancers (Basel). 2024; 16(20).

PMID: 39456578 PMC: 11506449. DOI: 10.3390/cancers16203484.


Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data.

Spreafico M, Hazewinkel A, Gelderblom H, Fiocco M Curr Oncol. 2024; 31(7):3630-3642.

PMID: 39057139 PMC: 11275318. DOI: 10.3390/curroncol31070267.


Follow-Up after Curative Surgical Treatment of Soft-Tissue Sarcoma for Early Detection of Recurrence: Which Patients Have More or Fewer Visits than Advised in Guidelines?.

Kruiswijk A, Kuhrij L, Dorleijn D, van de Sande M, van Bodegom-Vos L, Marang-van de Mheen P Cancers (Basel). 2023; 15(18).

PMID: 37760585 PMC: 10527323. DOI: 10.3390/cancers15184617.